Acute on chronic kidney disease
Granskad av Dr Hayley Willacy, FRCGP Senast uppdaterad av Dr Colin Tidy, MRCGPSenast uppdaterad 10 feb 2023
Uppfyller patientens redaktionella riktlinjer
- Ladda nerLadda ner
- Dela
- Language
- Diskussion
- Ask Patient
- Ljudversion
- Lägg till i föredragna källor på Google
Medicinska yrkesverksamma
Professionella referensartiklar är utformade för att användas av vårdpersonal. De är skrivna av brittiska läkare och baserade på forskningsbevis, brittiska och europeiska riktlinjer. Du kan hitta Akut njurskada artikel mer användbar, eller en av våra andra hälsoartiklar.
What is acute on chronic kidney disease?1
Patients with kronisk njursjukdom, especially in more advanced stages (eGFR less than 30 mL/min per 1·73 m²) often do not exhibit linear progression of disease, which might be related to superimposed episodes of akut njurskada or other factors. Some studies suggest that each acute kidney injury event might accelerate progression of chronic kidney disease.
Therefore, preventing acute kidney injury is an important part of the management of chronic kidney disease. This prevention involves avoiding acute kidney injury-associated drug combinations (eg, ACE inhibitors or angiotensin receptor blockers in conjunction with loop diuretics and non-steroidal anti-inflammatory drugs) and preventing infections that can precipitate hypotension or septic shock and requiring the use of potentially nephrotoxic antimicrobials.
Other potential contributors to acute kidney injury include cardiovascular events, particularly decompensated heart failure leading to venous congestion and impaired kidney blood flow, or coronary artery bypass and other major surgeries with possible intraoperative hypotensive episodes.
Therefore, any sudden decline in renal function in patients with known chronic kidney disease (CKD) requires rapid assessment, diagnosis and appropriate management to prevent an accelerated and possibly irreversible decline in renal function. CKD predisposes to episodes of acute kidney injury (AKI) and optimal care of CKD is essential to reduce the risk of AKI.2
The patient may be known to have CKD or may be presenting for the first time, having been previously not known to have CKD. There is also an association between AKI with incomplete recovery or lack of recovery and CKD.3
Management is directed towards identification and treatment of the underlying cause of the acute deterioration of renal function, and treatment for AKI. In addition to the morbidity and mortality associated with AKI, there is increasing evidence that AKI accelerates the progression of CKD.4
Causes of acute deterioration in chronic kidney disease5
Common causes
Systemic infection - eg, urinary tract infection (UTI), chest infection, central line.
Drugs - eg, diuretics, angiotensin-converting enzyme (ACE) inhibitors, aminoglycosides.
Uttorkning.
Urinary tract obstruction or urinary retention - eg, due to spinal cord compression or neurogenic bladder, or renal vein thrombosis (particularly in patients with nephrotic syndrome).
Other likely causes
Renal hypoperfusion secondary to dehydration from diarrhoea, diuretics, surgery or cardiac failure, pericardial tamponade, aortic dissection or renal vascular disease.
Metabolic and toxic causes - eg, diabetisk ketoacidos, hyperosmolär koma.
Progression of underlying diseases - eg, relapse of glomerulonefrit.
Development of accelerated-phase hypertension.
Pregnancy: at the end of the pregnancy or after delivery (eg, in patients with reflux nephropathy), pre-eclampsia, eclampsia.
Possible underlying causes of urinary retention and/or infection include:
Papillary necrosis and sloughing.
Stones.
Pelvic malignancy.
Bladder cancer.
Polycystic cysts.
Clot in the ureter.
Contrast media (especially in diabetes).
Presentation
The patient may present with the cause of the exacerbation (eg, local infection), features of chronic failure or may present with AKI.
Bedömning
Clinical assessment should include:
Identifying possible causes of acute exacerbation - eg, drug history, signs of infection or evidence of prostatic hypertrophy.
Identifying any degree of urinary tract obstruction.
Assessment of pre-existing renal function and whether an episode represents acute on chronic kidney disease or acute kidney injury in a patient with previously normal renal function (see the separate Chronic Kidney Disease och Acute Kidney Injury articles).
Assessment of blood pressure and general cardiovascular status.
Utredningar
Serial assessment of renal function: estimated GFR (eGFR), serum urea, creatinine and electrolytes.
Urine: urinalysis, microscopy, electrolytes and protein excretion.
FBC.
Infection swabs and cultures as appropriate.
ECG: evidence of hyperkalaemia, myocardial infarction.
Ultrasound scan of the urinary tract and lower abdomen to identify urinary tract obstruction or urinary tract abnormalities.
Further investigations and management will depend on the well-being of the patient, likely cause of the exacerbation and current renal function.
A full assessment, as described in the separate Acute Kidney Injury article, may be required.6
Njurbiopsi may also be required.
Differentialdiagnos
Other causes of raised urea and creatinine:
Raised urea can also be caused by intravascular volume depletion, diuretics, congestive heart failure, gastrointestinal bleeding, corticosteroids and tetracyclines.
Creatinine levels can be increased by muscle damage (rhabdomyolysis) and decreased tubular secretion - eg, cimetidine, trimethoprim.
Ingestion of cooked meat and severe exercise cause a rapid but temporary rise in serum creatinine.
Behandling och hantering
Management involves treatment of the underlying cause and management of acute injury.
Depending on the nature and certainty of the cause, clinical well-being and underlying renal function, patients often require referral to hospital for full assessment and appropriate management.
However, some patients with an obvious cause and who are clinically stable, may be safely managed at home.
Förebyggande
Regular monitoring and early effective treatment of any potential cause of acute deterioration of renal function.
Many commonly used drugs and procedures can potentially cause AKI, and patients with decreased GFR have an increased risk of drug-induced injury. Non-steroidal anti-inflammatory drugs, phosphorus-based enemas and iodinated contrast should particularly be avoided if possible.7
Exklusiva uppdateringar för vårdpersonal
Håll dig informerad med de senaste kliniska uppdateringarna, professionella insikter och evidensbaserad vägledning. Patient Pro-nyhetsbrevet sammanställer viktigt innehåll för vårdpersonal—levererat direkt till din inkorg.
Genom att prenumerera accepterar du våra Sekretesspolicy. Du kan avsluta prenumerationen när som helst. Vi säljer aldrig dina uppgifter.
Vidare läsning och referenser
- Acute kidney injury: prevention, detection and management; NICE Guidance (December 2019 - Last updated October 2024)
- Kronisk njursjukdom; NICE CKS, March 2024 (UK access only).
- Kronisk njursjukdom: bedömning och hantering; NICE riktlinje (senast uppdaterad november 2021)
- Woodrow G, Fan SL, Reid C, et al; Renal Association Clinical Practice Guideline on peritoneal dialysis in adults and children. BMC Nephrol. 2017 Nov 16;18(1):333. doi: 10.1186/s12882-017-0687-2.
- Kalantar-Zadeh K, Jafar TH, Nitsch D, et al; Chronic kidney disease. Lancet. 2021 Aug 28;398(10302):786-802. doi: 10.1016/S0140-6736(21)00519-5. Epub 2021 Jun 24.
- Fraser SD, Blakeman T; Chronic kidney disease: identification and management in primary care. Pragmat Obs Res. 2016 Aug 17;7:21-32. eCollection 2016.
- Heung M, Chawla LS; Acute kidney injury: gateway to chronic kidney disease. Nephron Clin Pract. 2014;127(1-4):30-4. doi: 10.1159/000363675. Epub 2014 Sep 24.
- Hsu RK, Hsu CY; The Role of Acute Kidney Injury in Chronic Kidney Disease. Semin Nephrol. 2016 Jul;36(4):283-92. doi: 10.1016/j.semnephrol.2016.05.005.
- Akut njurskada; NICE CKS, August 2021 (UK access only).
- Lameire N, Van Biesen W, Vanholder R; Acute kidney injury. Lancet. 2008 Nov 29;372(9653):1863-5.
- Levey AS, Coresh J; Chronic kidney disease. Lancet. 2012 Jan 14;379(9811):165-80. Epub 2011 Aug 15.
Om recensentenVisa fullständig biografi

Dr Hayley Willacy, FRCGP
Allmänläkare, Medicinsk Författare
MBChB (1992), DRCOG, DFFP, MRCOG (Part 1) MRCGP (2007), DFSRH (2013), MSc - medical education (2020)
Dr Hayley Willacy var en NHS-läkare som arbetade i nordvästra England och gick i pension från klinisk praktik 2022 efter 30 år.
Artikelhistorik
Artikeln finns också på Engelska, Tyska, Spanska, Franska, Italienska, Portugisiska, Hindi, Hebreiska, Arabiska, och Svenska.
Nästa granskning: 9 feb 2028
10 feb 2023 | Senaste versionen
Mer om njurrelaterade (njure) sjukdomar
- Autosomal dominant polycystisk njursjukdom
- Autosomalt recessiv polycystisk njursjukdom
- Kronisk njursjukdom
- Diabetisk nefropati
- Glomerulonefrit
- Hematuri
- Hemolytiskt uremiskt syndrom
- Hypokalemisk alkalos
- Hypofosfatemi
- Hypofosfatemisk rakit
- Interstitiella nefriter och nefrotoxiner
- Magnesiumstörningar
- Medullär svampnjure
- Nefrokalcinos
- Nefrotiskt syndrom
- Oliguri
- Njurcancer
- Njurersättningsbehandling och transplantation
- Renal tubulär sjukdom
- Urinvägsobstruktion


